China Reform Health controlling shareholder boosts stake, nears minimum target

On September 19, 2025, China Reform Health announced that its controlling shareholder, China Reform Holdings, and its concerted party, China Reform Development Investment Management, collectively increased their equity interest in the company. China Reform Development acquired an additional 7,681,327 shares on the Shenzhen Stock Exchange between September 17 and September 19, 2025, representing 0.78% of the total share capital. The total transaction amount for this increase was CNY 81,146,136.12.

Following this latest increase, China Reform Development's direct holdings in China Reform Health rose to 31,805,307 shares, or 3.24% of the total share capital, up from 2.46%. The combined stake of China Reform Holdings and China Reform Development now stands at 267,507,900 shares, representing 27.26% of the total share capital.

The current shareholding increase by the controlling shareholder and its concerted parties aligns with a plan announced on April 8, 2025, to increase holdings by CNY 100 million to CNY 200 million. While the recent increase has not yet reached the minimum target amount, the company's controlling shareholder and concerted parties will continue to implement the shareholding increase plan.